4
Changes in Ownership
INCYTE CORP Filed Acc 0002050035-26-000002
EVP, Head of US Oncology sold 10,856 shares at $109.07 ($1,184,064)
- EVP, Head of US Oncology gave up 8,264 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Issa Mohamed Khairie · EVP, Head of US Oncology
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-06 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −8,264 | $106.66 | $881,438 | 76,988 | D |
| 2026-01-07 | Sale : show line 2 in the form 10b5-1 | −10,856 | $109.07 | $1,184,064 | 66,132 | D |
| Open-market sales · 10,856 sh · avg $109.07 · $1,184,064 | ||||||
Loading xslF345X05/wk-form4_1767906216.xml…